Correlation Between Sabre Corpo and Opus Genetics,

Can any of the company-specific risk be diversified away by investing in both Sabre Corpo and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sabre Corpo and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sabre Corpo and Opus Genetics,, you can compare the effects of market volatilities on Sabre Corpo and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sabre Corpo with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sabre Corpo and Opus Genetics,.

Diversification Opportunities for Sabre Corpo and Opus Genetics,

-0.37

Correlation Coefficient

Sabre Corpo  Opus Genetics,

Very good diversification

The 3 months correlation between Sabre and Opus is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Sabre Corpo and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and Sabre Corpo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sabre Corpo are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of Sabre Corpo i.e., Sabre Corpo and Opus Genetics, go up and down completely randomly.

Pair Corralation between Sabre Corpo and Opus Genetics,

Given the investment horizon of 90 days Sabre Corpo is expected to under-perform the Opus Genetics,. But the stock apears to be less risky and, when comparing its historical volatility, Sabre Corpo is 2.0 times less risky than Opus Genetics,. The stock trades about 0.0 of its potential returns per unit of risk. The Opus Genetics, is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  109.00  in Opus Genetics, on September 27, 2024 and sell it today you would lose (1.00) from holding Opus Genetics, or give up 0.92% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

Sabre Corpo  vs.  Opus Genetics,

Sabre Corpo

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sabre Corpo are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable fundamental drivers, Sabre Corpo is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Opus Genetics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with Sabre Corpo and Opus Genetics,

The main advantage of trading using opposite Sabre Corpo and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sabre Corpo position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.

The idea behind Sabre Corpo and Opus Genetics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.